Mariner Investment Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-21,200
Closed -$4.9M 132
2016
Q2
$4.9M Buy
+21,200
New +$4.89M 1.65% 24
2015
Q4
Sell
-26,786
Closed -$7.28M 239
2015
Q3
$7.28M Buy
26,786
+16,786
+168% +$5.16M 1.47% 16
2015
Q2
$3.04M Buy
+10,000
New +$2.98M 0.78% 45
2015
Q1
Sell
-12,000
Closed -$3.09M 266
2014
Q4
$3.09M Buy
12,000
+7,300
+155% +$1.82M 0.53% 53
2014
Q3
$1.13M Buy
+4,700
New +$1.05M 0.23% 93

Other funds holding AGN

Mariner Investment Group's AGN Position: Q3 2016 in Review

Mariner Investment Group sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 21,200 shares — an estimated $4.9M sold.

Mariner Investment Group first reported a position in AGN in Q3 2014 and held it in 5 quarters. The position peaked at $7.28M in Q3 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Mariner Investment Group reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
  • Mariner Investment Group sold 21,200 Allergan plc shares in Q3 2016, an estimated $4.9M.
  • Mariner Investment Group first reported a position in Allergan plc in Q3 2014 and held it in 5 quarters.
  • Mariner Investment Group's Allergan plc position peaked at $7.28M in Q3 2015.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.